Monitoring of TCR clonotype and diversity of CD8+PD-1+ T-cells in lung cancer patients treated with PD-1 blockade: A Biomarker Study.
Not Applicable
Recruiting
- Conditions
- Treatment naive non-small cell lung cancer patients
- Registration Number
- JPRN-UMIN000043063
- Lead Sponsor
- ational Cancer Center Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients judged as inappropriate for the study by the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method